Gilbert Family Foundation Our Voice Play Video Featured Articles December 12, 2018 Gilbert Family Foundation Announces $12 Million Gene Therapy Initiative to Address Underlying Cause of NF1 Read More April 11, 2019 Gilbert Family Foundation Commits $11 Million to Combat Vision Loss in NF1 Patients Read More June 12, 2020 FDA Approves Selumetinib – What it Means for the NF Community and What’s Next? Read More July 13, 2020 NF Open Science Initiative – GFF’s New Partnership with Sage Bionetworks and Other NF Research Funders Read More August 17, 2020 Nothing Nonsensical About Nonsense Mutations: GTI Researchers Target One of the Most Common Types of NF1 Disease-Causing Genetic Mutations Read More September 14, 2020 GFF’s Guiding Values: Collaboration Read More October 13, 2020 GFF’s Vision Restoration Initiative: Exploring Neuroprotection/Neuroenhancement Therapies Read More November 16, 2020 GFF’s Vision Restoration Initiative: Exploring Regenerative Therapies Read More December 24, 2020 Seeking a True Cure: Developing Gene Replacement and Editing Therapies to Address the Cause of NF1 Read More
